Selected Publications
- Loh, A., Angelina, C., Wong, M. K., Tan, S. H., Sukhatme, S. A., Yeo, T., Lim, S. B., Lee, Y. T., Soh, S. Y., Leung, W., Chang, K., Chua, Y. W., Alkaff, S., Lim, T., Lim, C. T., & Chen, Z. X. (2022). Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse. Frontiers in oncology, 12, 939460.
- Kuick, C. H., Tan, J. Y., Jasmine, D., Sumanty, T., Ng, A., Venkatesh, B., Chen, H., Loh, E., Jain, S., Seow, W. Y., Ng, E., Lian, D., Soh, S. Y., Chang, K., Chen, Z. X., & Loh, A. (2022). Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma. BMC cancer, 22(1), 717.
- Wong, R. L. Y., Wong, M. R. E., Kuick, C. H., Saffari, S. E., . . . Chen, Z. X., Iyer, P., Tan, E. E. K., Soh, S. Y., Iyer, N. G., Fan, Q., and Loh, A. H. P. (2021). Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma.Front Oncol, 11, 709525.
- Hee, E., Wong, M. K., Tan, S. H., Choo, Z., . . . Chen, Z., Chang, K. T. E., and Loh, A. H. P. (2020). Neuroblastoma patient-derived cultures are enriched for a mesenchymal gene signature and reflect individual drug response. Cancer Sci, 111(10), 3780-3792. doi: 10.1111/cas.14610 (IF=6.716)
- Choo, Z., Loh, A. H. P., and Chen, Z. X. (2019). Destined to Die: Apoptosis and Pediatric Cancers. Cancers, 11(11), 1623. doi: 10.3390/cancers11111623 (IF=6.639)
- Angelina, C., Tan, I. S. Y., Choo, Z., Lee, O. Z. J., Pervaiz, S., and Chen, Z. X. (2017). KIF1Bbeta increases ROS to mediate apoptosis and reinforces its protein expression through O 2(-) in a positive feedback mechanism in neuroblastoma. Sci Rep, 7(1), 16867. doi:10.1038/s41598-017-17192-6 (IF=4.379)
- Cai, W., Xiong Chen, Z.#, Rane, G., Satendra Singh, S., Choo, Z., Wang, C., . . . Prem Kumar, A. (2017). Wanted DEAD/H or Alive: Helicases Winding Up in Cancers. J Natl Cancer Inst, 109(6). doi:10.1093/jnci/djw278 #co-first authors (IF=13.506)
- Li, S., Fell, S. M., Surova, O., Smedler, E., Wallis, K., Chen, Z. X., . . . Schlisio, S. (2016). The 1p36 Tumor Suppressor KIF 1Bbeta Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis. Dev Cell, 36(2), 164-178. doi:10.1016/j.devcel.2015.12.029 (IF=12.270)
- Chen, Z. X., Wallis, K., Fell, S. M., Sobrado, V. R., Hemmer, M. C., Ramskold, D., . . . Schlisio, S. (2014). RNA helicase A is a downstream mediator of KIF1Bbeta tumor-suppressor function in neuroblastoma. Cancer Discov, 4(4), 434-451. doi:10.1158/2159-8290.CD-13-0362 (IF=39.397)